Trypsin inhibitors demonstrate antioxidant activities, inhibit A549 cell proliferation, and increase activities of reactive oxygen species scavenging enzymes

Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of pharmacology Vol. 49; no. 2; pp. 155 - 160
Main Authors Shamsi, ToobaNaz, Parveen, Romana, Fatima, Sadaf
Format Journal Article
LanguageEnglish
Published India Medknow Publications and Media Pvt. Ltd 01.03.2017
Medknow Publications & Media Pvt. Ltd
Medknow Publications & Media Pvt Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role in the cell line. TIs were obtained from different plant sources. Antineoplastic potential on adenocarcinoma human alveolar basal epithelial cell line (A549) and normal Human Embryonic Kidney (HEK) was determined using MTT assay. Activities of antioxidant enzyme, nitric oxide scavenger, superoxide dismutase, glutathione S-transferase, and glutathione peroxidase were assessed in cell lines incubated with and without TIs. The outcome was analyzed by spectrophotometer. TIs showed the higher cytotoxicity on A549 cells as compared to normal HEK cell line. TIs exhibited fair increase in antioxidant enzyme activity in A549 cells as compared to control. This might be one of the strategies of antineoplastic effect in cancer cells. This study has reported the antioxidant and antineoplastic properties of these TIs for the first time in A549 cells (to the best of our knowledge). The results show that TIs possess ability to prevent cancer and diseases caused due to oxidative stress. Therefore, we conclude that TIs can be used as supplements along with the conventional drugs for increased efficacy in the treatment of diseases such as cardiovascular disease, atherosclerosis, and cancer.
AbstractList Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role in the cell line. TIs were obtained from different plant sources. Antineoplastic potential on adenocarcinoma human alveolar basal epithelial cell line (A549) and normal Human Embryonic Kidney (HEK) was determined using MTT assay. Activities of antioxidant enzyme, nitric oxide scavenger, superoxide dismutase, glutathione S-transferase, and glutathione peroxidase were assessed in cell lines incubated with and without TIs. The outcome was analyzed by spectrophotometer. TIs showed the higher cytotoxicity on A549 cells as compared to normal HEK cell line. TIs exhibited fair increase in antioxidant enzyme activity in A549 cells as compared to control. This might be one of the strategies of antineoplastic effect in cancer cells. This study has reported the antioxidant and antineoplastic properties of these TIs for the first time in A549 cells (to the best of our knowledge). The results show that TIs possess ability to prevent cancer and diseases caused due to oxidative stress. Therefore, we conclude that TIs can be used as supplements along with the conventional drugs for increased efficacy in the treatment of diseases such as cardiovascular disease, atherosclerosis, and cancer.
OBJECTIVES: Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role in the cell line. MATERIALS AND METHODOLOGY: TIs were obtained from different plant sources. Antineoplastic potential on adenocarcinoma human alveolar basal epithelial cell line (A549) and normal Human Embryonic Kidney (HEK) was determined using MTT assay. Activities of antioxidant enzyme, nitric oxide scavenger, superoxide dismutase, glutathione S-transferase, and glutathione peroxidase were assessed in cell lines incubated with and without TIs. The outcome was analyzed by spectrophotometer. RESULTS: TIs showed the higher cytotoxicity on A549 cells as compared to normal HEK cell line. TIs exhibited fair increase in antioxidant enzyme activity in A549 cells as compared to control. This might be one of the strategies of antineoplastic effect in cancer cells. CONCLUSIONS: This study has reported the antioxidant and antineoplastic properties of these TIs for the first time in A549 cells (to the best of our knowledge). The results show that TIs possess ability to prevent cancer and diseases caused due to oxidative stress. Therefore, we conclude that TIs can be used as supplements along with the conventional drugs for increased efficacy in the treatment of diseases such as cardiovascular disease, atherosclerosis, and cancer.
Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role in the cell line.OBJECTIVESProtease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role in the cell line.TIs were obtained from different plant sources. Antineoplastic potential on adenocarcinoma human alveolar basal epithelial cell line (A549) and normal Human Embryonic Kidney (HEK) was determined using MTT assay. Activities of antioxidant enzyme, nitric oxide scavenger, superoxide dismutase, glutathione S-transferase, and glutathione peroxidase were assessed in cell lines incubated with and without TIs. The outcome was analyzed by spectrophotometer.MATERIALS AND METHODOLOGYTIs were obtained from different plant sources. Antineoplastic potential on adenocarcinoma human alveolar basal epithelial cell line (A549) and normal Human Embryonic Kidney (HEK) was determined using MTT assay. Activities of antioxidant enzyme, nitric oxide scavenger, superoxide dismutase, glutathione S-transferase, and glutathione peroxidase were assessed in cell lines incubated with and without TIs. The outcome was analyzed by spectrophotometer.TIs showed the higher cytotoxicity on A549 cells as compared to normal HEK cell line. TIs exhibited fair increase in antioxidant enzyme activity in A549 cells as compared to control. This might be one of the strategies of antineoplastic effect in cancer cells.RESULTSTIs showed the higher cytotoxicity on A549 cells as compared to normal HEK cell line. TIs exhibited fair increase in antioxidant enzyme activity in A549 cells as compared to control. This might be one of the strategies of antineoplastic effect in cancer cells.This study has reported the antioxidant and antineoplastic properties of these TIs for the first time in A549 cells (to the best of our knowledge). The results show that TIs possess ability to prevent cancer and diseases caused due to oxidative stress. Therefore, we conclude that TIs can be used as supplements along with the conventional drugs for increased efficacy in the treatment of diseases such as cardiovascular disease, atherosclerosis, and cancer.CONCLUSIONSThis study has reported the antioxidant and antineoplastic properties of these TIs for the first time in A549 cells (to the best of our knowledge). The results show that TIs possess ability to prevent cancer and diseases caused due to oxidative stress. Therefore, we conclude that TIs can be used as supplements along with the conventional drugs for increased efficacy in the treatment of diseases such as cardiovascular disease, atherosclerosis, and cancer.
Audience Academic
Author Shamsi, ToobaNaz
Parveen, Romana
Fatima, Sadaf
AuthorAffiliation Department of Biotechnology, Jamia Millia Islamia, New Delhi, India
AuthorAffiliation_xml – name: Department of Biotechnology, Jamia Millia Islamia, New Delhi, India
Author_xml – sequence: 1
  givenname: ToobaNaz
  surname: Shamsi
  fullname: Shamsi, ToobaNaz
– sequence: 2
  givenname: Romana
  surname: Parveen
  fullname: Parveen, Romana
– sequence: 3
  givenname: Sadaf
  surname: Fatima
  fullname: Fatima, Sadaf
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28706328$$D View this record in MEDLINE/PubMed
BookMark eNp1kktvEzEUhS1URB-wZYkssWHRCWN7PHY2SFHFo6gSLMracjx3UkcTe7AnUcN_4b9yhzZNi4JmYdn-zvHce88pOQoxACGvWTmpWCne-2U_ufz63UgpDKufkRM2nepCKMmOyEnJpShUzcQxOc15WeK-mtYvyDHXqqwF1yfk93Xa9tkH6sONn_shpkwbWMWQh2QHoDYMPt76Bldq3eA3fvCQz3c4naEjddB1tE-x8y2gysdwjsIGIZfAZnikpLGleDbugcbb7QICzT248So7u4Gw8GFBIfzariC_JM9b22V4db-ekR-fPl5ffCmuvn2-vJhdFU5yMRStVVLLqm641SAqwSvNnVIaOzTXgjXKMd6Ucy5ZoxtRczVVVjLFVd0KbeetOCMf7nz79XwFjYOA1XemT35l09ZE683Tm-BvzCJuDFavKqHQ4N29QYo_15AHs_J5bIsNENfZsCkveVnqiiP69h90GdcpYHkjJVQtea331MJ2YHxoI77rRlMzwxlKxjUfvYoDFPYUx9BhUFqPx0_4yQEePxy5dwcFbx435qEjuwAhUN0BLsWcE7TG-eFvBNDZd4aVZsypwZyafU73P_Ig2zn_R_AH12jtBw
CitedBy_id crossref_primary_10_3390_molecules23061251
crossref_primary_10_1002_cbf_3845
crossref_primary_10_1080_19476337_2021_1971771
crossref_primary_10_3390_ijms22073543
crossref_primary_10_1016_j_lfs_2019_117044
crossref_primary_10_30901_2227_8834_2020_3_25_31
crossref_primary_10_1021_acs_jafc_3c08711
ContentType Journal Article
Copyright COPYRIGHT 2017 Medknow Publications and Media Pvt. Ltd.
Copyright Medknow Publications & Media Pvt. Ltd. Mar/Apr 2017
Copyright: © 2017 Indian Journal of Pharmacology 2017
Copyright_xml – notice: COPYRIGHT 2017 Medknow Publications and Media Pvt. Ltd.
– notice: Copyright Medknow Publications & Media Pvt. Ltd. Mar/Apr 2017
– notice: Copyright: © 2017 Indian Journal of Pharmacology 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.4103/ijp.IJP_553_16
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Research Library (ProQuest)
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1998-3751
EndPage 160
ExternalDocumentID PMC5497437
A496512822
28706328
10_4103_ijp_IJP_553_16
Genre Journal Article
GroupedDBID ---
29I
2WC
53G
5GY
5VS
7X7
88E
8FI
8FJ
8G5
96U
AAYXX
ABDBF
ABJNI
ABUWG
ABVJJ
ACGFO
ACGFS
ACIHN
ACUHS
ADBBV
ADJBI
ADRAZ
AEAQA
AENEX
AFAZI
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BENPR
BPHCQ
BVXVI
C1A
CCPQU
CITATION
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
EOJEC
ESX
F5P
FRP
FYUFA
GNUQQ
GUQSH
GX1
H13
HH5
HMCUK
HYE
IAO
IEA
IHE
IHR
IL9
INH
INR
IOF
ITC
KQ8
M1P
M2O
M48
MK0
O5R
O5S
OBODZ
OK1
OVD
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBI
RMW
RNS
RPM
TEORI
TR2
TUS
UKHRP
W2D
XSB
~8M
2CU
3V.
ABXLX
CGR
CUY
CVF
ECM
EIF
GROUPED_DOAJ
M~E
NPM
PMFND
7XB
8FK
K9.
MBDVC
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c523t-fa758546d2a8e3432482c778410b831d7c12d0b251d8d362797a517276f38abf3
IEDL.DBID M48
ISSN 0253-7613
1998-3751
IngestDate Thu Aug 21 13:49:20 EDT 2025
Thu Jul 10 22:34:00 EDT 2025
Fri Jul 25 23:09:45 EDT 2025
Tue Jun 17 21:03:02 EDT 2025
Thu Jun 12 23:47:50 EDT 2025
Tue Jun 10 20:14:22 EDT 2025
Thu Jan 02 23:12:02 EST 2025
Tue Jul 01 01:12:24 EDT 2025
Thu Apr 24 22:53:34 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords lung cancer
Antioxidant
protein
protein protease inhibitors
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c523t-fa758546d2a8e3432482c778410b831d7c12d0b251d8d362797a517276f38abf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4103/ijp.IJP_553_16
PMID 28706328
PQID 1923765268
PQPubID 28295
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5497437
proquest_miscellaneous_1920200842
proquest_journals_1923765268
gale_infotracmisc_A496512822
gale_infotracgeneralonefile_A496512822
gale_infotracacademiconefile_A496512822
pubmed_primary_28706328
crossref_citationtrail_10_4103_ijp_IJP_553_16
crossref_primary_10_4103_ijp_IJP_553_16
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-03-01
PublicationDateYYYYMMDD 2017-03-01
PublicationDate_xml – month: 03
  year: 2017
  text: 2017-03-01
  day: 01
PublicationDecade 2010
PublicationPlace India
PublicationPlace_xml – name: India
– name: Pondicherry
PublicationTitle Indian journal of pharmacology
PublicationTitleAlternate Indian J Pharmacol
PublicationYear 2017
Publisher Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Medknow Publications & Media Pvt Ltd
Publisher_xml – name: Medknow Publications and Media Pvt. Ltd
– name: Medknow Publications & Media Pvt. Ltd
– name: Medknow Publications & Media Pvt Ltd
References 21516412 - Methods Mol Biol. 2011;731:237-45
27506886 - Food Funct. 2016 Sep 14;7(9):3868-79
22916809 - Br J Nutr. 2012 Aug;108 Suppl 1:S135-44
19574654 - Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jul 1;65(Pt 7):736-8
15972265 - Comp Biochem Physiol A Mol Integr Physiol. 2005 Oct;142(2):111-7
27043143 - PLoS One. 2016 Apr 04;11(4):e0152925
26955746 - Int J Biol Macromol. 2016 Oct;91:1120-33
23306898 - Appl Biochem Biotechnol. 2013 Feb;169(4):1306-14
27379315 - Int Sch Res Notices. 2014 Oct 29;2014:568081
21969071 - Arch Toxicol. 2012 Feb;86(2):293-304
21749277 - Free Radic Res. 2011 Oct;45(10):1154-61
22454771 - Biochem Res Int. 2012;2012:454368
26273424 - Oxid Med Cell Longev. 2015;2015:750798
25061412 - Saudi Pharm J. 2014 Jul;22(3):264-72
27461591 - J Cancer Res Ther. 2016 Apr-Jun;12 (2):438-46
26659465 - PLoS One. 2015 Dec 11;10(12):e0144509
23558240 - Pancreas. 2013 May;42(4):614-21
27410459 - PLoS One. 2016 Jul 13;11(7):e0158942
26907338 - Nutrients. 2016 Feb 23;8(3):110
23305162 - BMC Complement Altern Med. 2013 Jan 10;13:12
References_xml – reference: 25061412 - Saudi Pharm J. 2014 Jul;22(3):264-72
– reference: 27461591 - J Cancer Res Ther. 2016 Apr-Jun;12 (2):438-46
– reference: 26907338 - Nutrients. 2016 Feb 23;8(3):110
– reference: 22454771 - Biochem Res Int. 2012;2012:454368
– reference: 27043143 - PLoS One. 2016 Apr 04;11(4):e0152925
– reference: 27379315 - Int Sch Res Notices. 2014 Oct 29;2014:568081
– reference: 26273424 - Oxid Med Cell Longev. 2015;2015:750798
– reference: 21749277 - Free Radic Res. 2011 Oct;45(10):1154-61
– reference: 15972265 - Comp Biochem Physiol A Mol Integr Physiol. 2005 Oct;142(2):111-7
– reference: 27506886 - Food Funct. 2016 Sep 14;7(9):3868-79
– reference: 23306898 - Appl Biochem Biotechnol. 2013 Feb;169(4):1306-14
– reference: 27410459 - PLoS One. 2016 Jul 13;11(7):e0158942
– reference: 21516412 - Methods Mol Biol. 2011;731:237-45
– reference: 26659465 - PLoS One. 2015 Dec 11;10(12):e0144509
– reference: 23305162 - BMC Complement Altern Med. 2013 Jan 10;13:12
– reference: 19574654 - Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jul 1;65(Pt 7):736-8
– reference: 22916809 - Br J Nutr. 2012 Aug;108 Suppl 1:S135-44
– reference: 23558240 - Pancreas. 2013 May;42(4):614-21
– reference: 26955746 - Int J Biol Macromol. 2016 Oct;91:1120-33
– reference: 21969071 - Arch Toxicol. 2012 Feb;86(2):293-304
SSID ssj0025496
Score 2.150488
Snippet Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed...
OBJECTIVES: Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 155
SubjectTerms A549 Cells
Acids
Antineoplastic Agents - pharmacology
Antioxidants
Antioxidants (Nutrients)
Antioxidants - pharmacology
Apoptosis
Biotechnology
Cancer
Cell adhesion & migration
Cell cycle
Cell growth
Cell Proliferation - drug effects
Cell Survival - drug effects
Cytotoxicity
Enzymes
Garlic
Glutathione Peroxidase - metabolism
Glutathione Transferase - metabolism
HEK293 Cells
Humans
Metastasis
Oxidative stress
Phaseolus
Physiological aspects
Reactive oxygen species
Reactive Oxygen Species - metabolism
Seeds
Signal transduction
Superoxide Dismutase - metabolism
Trypsin inhibitors
Trypsin Inhibitors - pharmacology
Vigna
SummonAdditionalLinks – databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9NAEF1BuXBBfBMoaJFQuMTU9tpe94QiRFV6QDmkUm6W98PUiDqmTlHNf-G_Mm_txDECTpGys5atmZ19szvzhrE3ZBIEQiWtNJH7XqSVAAek8VSgaH9SRWStS5D9nJyeR2ereNUfuDV9WuXWJzpHbdYaZ-RHQCIyATnJ-_q7h65RuF3tW2jcZndAXQarlqsh4KLYx91VhrHwKFwXHWljFPjiqPxav_t0tsjiWGTodb63Kf3pmvf2pnHe5N5GdHKf3esRJJ93Kn_AbtnqIZsuOgrqdsaXQ0VVM-NTvhjIqdtH7Nfyqq2bsuJldVGqEr12uLGXQIkgjeA5sh9vSkO_HDUPPxzj6mwrzuf0tRyn_bxGv5_CdhY0o4mGhIBBG7s3k68LTv85r8rXNy3ZK0d1J4YajV726JLEbfWzvbTNY3Z-8nH54dTrWzR4miLYjVfkiDeixIR5alGjGqWhlrjL9FUqAiN1EBpfEYgyqaG9Uh7LPAZmSgqR5qoQT9hBta7sM8YTk5sgiXUaWFDai1SR6zMU0KnkOFJGTpi31VGme_5ytNH4llEcA51mpNNs0OmEvd3J1x1zx78lofIMS5qeqPO-MoHeC-RY2Ryc-gHybSdsOpL80lGD_03wcCRIa1aPh7fWlfU-o8kGC5-w17thzEQeXGXX107GR8ZKRI942hnj7uPclbUIabYcmelOAEzi45GqvHCM4mQ6hCTl8_-_1gt2NwSocRl4h-xgc3VtXxIk26hXbt39BqDDOW8
  priority: 102
  providerName: ProQuest
Title Trypsin inhibitors demonstrate antioxidant activities, inhibit A549 cell proliferation, and increase activities of reactive oxygen species scavenging enzymes
URI https://www.ncbi.nlm.nih.gov/pubmed/28706328
https://www.proquest.com/docview/1923765268
https://www.proquest.com/docview/1920200842
https://pubmed.ncbi.nlm.nih.gov/PMC5497437
Volume 49
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB7R9sIF8ca0RIuEwiUOsdf2uicUUKtSiSpCiZTbyutdU6PWSeMUxfwX_iszfiVG4cIpUnbGijMzO99oZ78BeIcugSBUYKTxaGR7seLEAalt5SjMTyrxjCkbZK-Ci5l3Offn2_6n-g_M95Z2NE9qtroZbu6KjxjwiF-HnjPiH9Ify-GXy4n0fS6d4ACOMCsJmmbw1WtPFKgOKs8tXZ_bWLrzisBxjz7RA9PhH6cB7Tu56u8deydlddspd_LT-WN4VANLNq484Qk8MNlT6E8qZupiwKbbi1b5gPXZZMtZXTyD39NVsczTjKXZdapSGsHDtLkl8EhcEiyipshNqvGT0VWInyUR66ARZ2N8cUaHAGxJY4ASUznWABU1ChE0zc2OJlskDL8rN1u22BToxowufdJSHtOIexqexEz2q7g1-XOYnZ9NP1_Y9eQGO8bCdm0nEZUhXqDdKDR0ddUL3VjQEedIhdzRInZcPVKIrXSoMYWKUxH5BKWChIeRSvgLOMwWmXkFLNCRdgI_Dh1DTPc8VLgjarSQCk49pYUFdmMjGde05jRd40ZieUPmlWheuTWvBe9b-WVF6PFvSTK5JN_DJ8ZRfWEBfxdxZskxUe071IZrQb8j-b1iDN8neNIRxFCOu8uNd8kmEiRBcBEQK48Fb9tl0qT2uMws7kuZETWyePiIl5Uzti_XOLMFouOmrQARjHdXsvS6JBpH10GAKV7_t-YxPHQJBpU9eydwuF7dmzcI4taqBwdiLnpw9OnsavKtV8bqH8osTKk
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VcoAL4k2gwCJBuMTU73UPCEVAlbSlyiGVclu8D1NXrW3qFGr-C3-B38jM2o5jBNx6ipSdXdma2Xl4Zr4h5CWIBDihDG6aF9uWL4WHGJDKEo4A-yQSX2tTIHsYTo78vUWw2CC_2l4YLKtsdaJR1CqX-I18Gz0RFiI4ybviq4VTozC72o7QqMViX1ffIWQr304_AH9fue7ux_n7idVMFbAkBF1LK4nRRfZD5caRxrZKP3Ilw_SbLSLPUUw6rrIF2H0VKVDvbIfFAZr5MPGiWCQenHuNXAfDa2OwxxZdgAexlsmNuoFnMbCTNUgkHOxtpyfFm-nejAeBx3G2-poR_NMUrNnCfp3mmuHbvU1uNR4rHdcidods6OwuGc5qyOtqROddB1c5okM668Cwq3vk5_y8Kso0o2l2nIoUZ_tQpc_QK0WQChpjteVlquCXYo_FN4PwOmrJ6RjelmJ2gRY4XyjRtcSOYKMCIvR5S722k-YJhf-MFqf5ZQX3g2I3KS6VMgbVjlOZqM5-VGe6vE-OroR5D8hmlmf6EaGhipUTBjJyNELoe5EAVasggBThji8UGxCr5RGXDV46ju045RA3IU858JR3PB2Q1yv6okYK-TclspyjCoETZdx0QsBzIRgXHyOGv4P1vQMy7FF-qaHI_0a41SMEHSH7y6108UZHlby7UQPyYrWMO7HuLtP5haGxsULGhyMe1sK4ejmTIvdc2M16YroiQOTy_kqWHhsEcxAd8FzZ4_8_1nNyYzL_dMAPpof7T8hNFx0qU_23RTaX5xf6KbiDS_HM3EFKPl_1pf8NAa9z2A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trypsin+inhibitors+demonstrate+antioxidant+activities%2C+inhibit+A549+cell+proliferation%2C+and+increase+activities+of+reactive+oxygen+species+scavenging+enzymes&rft.jtitle=Indian+journal+of+pharmacology&rft.au=Shamsi%2C+Tooba+Naz&rft.au=Parveen%2C+Romana&rft.au=Fatima%2C+Sadaf&rft.date=2017-03-01&rft.pub=Medknow+Publications+%26+Media+Pvt+Ltd&rft.issn=0253-7613&rft.eissn=1998-3751&rft.volume=49&rft.issue=2&rft.spage=155&rft.epage=160&rft_id=info:doi/10.4103%2Fijp.IJP_553_16&rft_id=info%3Apmid%2F28706328&rft.externalDocID=PMC5497437
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0253-7613&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0253-7613&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0253-7613&client=summon